Oncology Corporate Profile
amida Cell Ltd.is a leader in cellular and immune therapy. The company develops novel curative treatments for orphan hematological diseases and malignancies using stem cells and NK cells. Gamida Cell’s therapeutic products are allogeneic (the cells are not sourced from the patient) and do not involve genetic interference. The manufacturing processes which utilize the proprietary platform NAM technology are robust, cost-effective and efficient for commercial production. Gamida Cell’s technologies and products are protected by worldwide patents and numerous patent applications. Gamida Cell owns all worldwide rights to all products in development.